News

With its Poolbeg Pharma merger plans having bitten the dust and key assets sold off to Gilead, Hookipa Pharma has decided ...
In December 1871, fire tore through Warwick's medieval castle, reducing its magnificent entrance hall and private apartments to ashes. "The servants were woken up with what they thought was hail and ...
The Handmaid’s Tale is an American dystopian series adapted by Bruce Miller and based on Margaret Atwood’s 1985 classic.
South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...
Stocks closed lower on Wall Street, pulling the S&P 500 and the Nasdaq composite below the records they set a day earlier.
In the highly regulated world of life sciences, quality isn’t a box to check—it’s a business imperative. For global en ...
Stocks are lower on Wall Street, pulling the S&P 500 below the record it set a day earlier. The S&P 500 was down 0.2% in ...
Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.
But in the last six months, the sudden withdrawal of U.S. money has caused a “systemic shock,” U.N. officials warned, adding ...
Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the ...
A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable will be the next challenge.
Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P 500’s modest 2% gain.